Affiliation
Department of Rheumatology, Cork University Hospital, Wilton, Cork, Ireland. grainne.murphy@ucc.ieIssue Date
2009-10MeSH
Antibodies, MonoclonalAntibodies, Monoclonal, Humanized
Antirheumatic Agents
Arthritis, Rheumatoid
Female
Humans
Immunity, Innate
Incidence
Listeria monocytogenes
Listeriosis
Middle Aged
Risk Factors
Tumor Necrosis Factor-alpha
Metadata
Show full item recordCitation
Systemic listeriosis with adalimumab therapy. 2009, 15 (7):369-70 J Clin RheumatolJournal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesDOI
10.1097/RHU.0b013e3181bf93cdPubMed ID
20009978Item Type
ArticleLanguage
enISSN
1536-7355ae974a485f413a2113503eed53cd6c53
10.1097/RHU.0b013e3181bf93cd
Scopus Count
Collections
Related articles
- Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
- Authors: van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA
- Issue date: 2006 Oct
- Mycobacterium chelonae infection associated with adalimumab therapy.
- Authors: Díaz F, Urkijo JC, Mendoza F, de la Viuda JM, Blanco M, Unzurrunzaga A, Ayarza R
- Issue date: 2008 Mar-Apr
- Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
- Authors: Nagashima T, Minota S
- Issue date: 2011 Mar
- Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
- Authors: Baltà-Cruz S, Alsina-Glbert M, Mozos-Rocafort A, Cervera C, Colomo-Saperas L, Del Río A, Estrach-Panella T
- Issue date: 2009
- Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
- Authors: Hyrich KL, Silman AJ
- Issue date: 2006 May